Durham’s Fennec Pharmaceuticals raises $7.6M
Biotech company Fennec Pharmaceuticals has raised $7.6 million in a private equity offering, according to a filing Thursday with the Securities and Exchange Commission. The money came from seven investors who purchased 1.9 million shares at $4 per share, according to the filing. Essetifin SpA, which owned 2.6 million shares, or 19.2 percent, of Fennec prior to the offering, purchased an additional 300,000 shares and now owns more than 21 percent of the Durham-based company. Fennec said it will use the money to develop one of its drugs and for general corporate purposes. “The investment and support received by...
Read More